Fits and Starts: Trial Results from the CTAD Conference
Latest on investigational treatments in the pipeline. Two-part series on recent results published at the CTAD Conference from Pat McCaffrey for the Alz Forum.
Latest on investigational treatments in the pipeline. Two-part series on recent results published at the CTAD Conference from Pat McCaffrey for the Alz Forum.
Merck shook the field with news that people on verubecestat scored worse than those on placebo – find out more in this post from AlzForum
Developing computational algorithms & machine-learning techniques, to transform cross-sectional imaging data to a longitudinal picture and reconstruct the sequence of disease progression.
Many genetic variants predispose to Alzheimer’s disease, but exactly how remains a mystery.
In AD, tau tangles correlate closely with neurodegeneration, but how they work their mischief remains unclear… or does it?
For everything there is a season—perhaps even cognition?
Check out the “booths” in this new section of the AlzForum to learn about products and services that could accelerate your research.
https://www.alzforum.org/news/research-news/does-daytime-drowsiness-foreshadow-av-accumulation
Get all the support you need sent straight to your inbox. Research news, oppertunities, blogs, podcasts, jobs, events, funding calls and much more – every friday!